Can you provide a perspective on what subset of patients treated with guideline-directed T4 monotherapy may continue to have persistent hypothyroid symptoms, how large this subpopulation is based on clinical studies, and how you rule out other causes of these symptoms?
Can you provide a perspective on what subset of patients treated with guideline-directed T4 monotherapy may continue to have persistent hypothyroid symptoms, how large this subpopulation is based on clinical studies, and how you rule out other causes of these symptoms?
Professor of Medicine, Uniformed Services University of the Health SciencesDirector, Endocrinology Division, Uniformed Services University of the Health Sciences Walter Reed National Military Medical CenterEndocrinology, Diabetes & MetabolismBethesda, MD
